Your browser doesn't support javascript.
loading
Pancreatic cancer risk to siblings of probands in bilineal cancer settings.
Rabe, Kari G; Stevens, Maria A; Hernández, Amanda Toledo; Chandra, Shruti; Hubbard, Joleen M; Kemppainen, Jennifer L; Majumder, Shounak; Petersen, Gloria M.
Afiliación
  • Rabe KG; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.
  • Stevens MA; Division of Health Care Policy and Research, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN.
  • Hernández AT; School of Medicine, Medical Science Campus, University of Puerto Rico, San Juan, Puerto Rico.
  • Chandra S; Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.
  • Hubbard JM; Department of Medical Oncology, Mayo Clinic, Rochester, MN.
  • Kemppainen JL; Department of Clinical Genomics, Mayo Clinic, Rochester, MN.
  • Majumder S; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
  • Petersen GM; Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN. Electronic address: Petersen.Gloria@mayo.edu.
Genet Med ; 24(5): 1008-1016, 2022 05.
Article en En | MEDLINE | ID: mdl-35227607
PURPOSE: Pancreatic cancer (PC) risk is increased in families, but PC risk and risk perception have been understudied when both parents have cancer. METHODS: An unbiased method defining cancer triads (proband with PC and both parents with cancer) in a prospective registry estimated risk of PC to probands' siblings in triad group 1 (no parent with PC), group 2 (1 parent with PC), and group 3 (both parents with PC). We estimated standardized incidence ratios (SIRs) using a Surveillance, Epidemiology, and End Results (SEER) reference. We also estimated the risk when triad probands carried germline pathogenic/likely pathogenic variants in any of the 6 PC-associated genes (ATM, BRCA1, BRCA2, CDKN2A, MLH1, and TP53). PC risk perception/concern was surveyed in siblings and controls. RESULTS: Risk of PC was higher (SIR = 3.5; 95% CI = 2.2-5.2) in 933 at-risk siblings from 297 triads. Risk increased by triad group: 2.8 (95% CI = 1.5-4.5); 4.5 (95% CI = 1.6-9.7); and 21.2 (95% CI = 4.3-62.0). SIR in variant-negative triads was 3.0 (95% CI = 1.6-5.0), whereas SIR in variant-positive triads was 10.0 (95% CI = 3.2-23.4). Siblings' perceived risk/concern of developing PC increased by triad group. CONCLUSION: Sibling risks were 2.8- to 21.2-fold higher than that of the general population. Positive variant status increased the risk in triads. Increasing number of PC cases in a triad was associated with increased concern and perceived PC risk.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Hermanos Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Genet Med Asunto de la revista: GENETICA MEDICA Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Hermanos Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Genet Med Asunto de la revista: GENETICA MEDICA Año: 2022 Tipo del documento: Article